Author: Karen Walsh

VanEck’s Pharma ETF offers lower costs and stability; Invesco’s Biotech ETF chases higher returns with steeper risk. Which fits your portfolio?

Boston Scientific director Habiger bought $100K in BSX shares, expanding his stake 14% as the stock sits near a 54% decline and multi-year lows.

A $2 million retirement nest egg sounds like freedom, but taxes, healthcare costs, inflation, and withdrawal timing can erode it faster than most retirees expect.

Global X Silver Miners returned 49% in one year. SPDR Gold Shares holds $134.6B in assets. The choice between them is really about volatility tolerance.

Stock futures pointed sharply lower Friday as chip stocks extended their sell-off. Oil prices rose after the U.S. struck Iranian infrastructure, complicating market sentiment.

Gas prices hit their lowest since the Iran conflict began, then reversed sharply as oil climbed again. Here’s what’s driving the swing.

Stock futures pointed higher Monday as tech rebounded from weekly losses. Oil rose modestly after U.S.-Iran military exchanges, while Comcast surged on split plans.

Some home sellers want OpenAI or Anthropic shares instead of cash. The valuation, tax, and legal obstacles make it far harder than it sounds.

The DRAM ETF bundles Micron, SK Hynix, Samsung, and Sandisk under $100 as AI-driven memory demand tightens supply and lifts producer margins.

Stock futures rose Thursday after major indexes fell, as traders dismissed U.S.-Iran strikes. Oracle dropped on high AI spending; other AI stocks gained.